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High Frequency Retrotransposition
in Cultured Mammalian Cells
John V. Moran,* Susan E. Holmes,*† Thierry P. Naas,* Eickbush, 1995; Moran et al., 1995; Zimmerly et al.,
1995a, 1995b).Ralph J. DeBerardinis,* Jef D. Boeke,‡
and Haig H. Kazazian, Jr.* L1s (or LINEs, for long interspersed nuclear elements)
are non-LTR retrotransposons present in 105 copies in*Department of Genetics
University of Pennsylvania School of Medicine all mammalian genomes and comprise roughly 5% of
genomic DNA (Burton et al., 1986; Hutchison et al.,Philadelphia, Pennsylvania 19104
‡Department of Molecular Biology and Genetics 1989). In humans, about 3000 L1s are full length (Singer
et al., 1993). The remaining 97% are variably 59 trun-The Johns Hopkins School of Medicine
Baltimore, Maryland 21205 cated, and some contain internal rearrangements. Se-
quence analysis of multiple human L1s led to the deriva-
tion of a 6.0 kb consensus sequence (Scott et al., 1987)
that contains a 59 untranslated region (59UTR) with anSummary
internal promoter (Swergold, 1990; Minakami et al.,
1992), two nonoverlapping open reading frames (ORF1We previously isolated two human L1 elements (L1.2
and ORF2), a 205 bp 39UTR, and a 39 poly(A) tail; it isand LRE2) as the progenitors of disease-producing
usually flanked by target site duplications that rangeinsertions. Here, we show these elements can actively
from 7 to 20 bp (Figure 1A). ORF1 encodes a 40 kDaretrotranspose in cultured mammalian cells. When
nucleic acid–binding protein (Holmes et al., 1992; Hoh-stably expressed from an episome in HeLa cells, both
joh and Singer, 1996), while ORF2 has sequence similar-elements retrotransposed into a variety of chromo-
ity to the reverse transcriptases (RTs) of other retroele-somal locations at a high frequency. The retrotrans-
ments (Hattori et al., 1986; Xiong and Eickbush, 1990).posed products resembled endogenous L1 insertions,
ORF2 also contains an N-terminal endonuclease (EN)since they were variably 59 truncated, ended in poly(A)
domain (Feng et al., 1996 [this issue of Cell]) and atracts, and were flanked by target-site duplications or
C-terminal cysteine-rich motif (C) (Fanning and Singer,short deletions. Point mutations in conserved domains
1987a; Figure 1A).of the L1.2-encoded proteins reduced retrotransposi-
L1 retrotranspositions have resulted in genetic dis-tion by 100- to 1000-fold. Remarkably, L1.2 also retro-
ease in humans (Kazazian et al., 1988; Morse et al., 1988;transposed in a mouse cell line, suggesting a potential
Miki et al., 1992; Narita et al., 1993; Holmes et al., 1994),role for L1-based vectors in random insertional muta-
mice (Kingsmore et al., 1994; Mu¨lhardt et al., 1994; Korh-genesis.
man et al., 1996; Takahara et al., 1996), and dogs (Katzir
et al., 1985). Thus, it is clear that L1 retrotranspositions
Introduction are mutagenic, ongoing events that alter mammalian
genomes. However, lack of an experimental system to
Retroelements are present in the nuclear genomes of study retrotransposition has hampered progress in the
all eukaryotes, the mitochondrial genomes of certain retrotransposon field.
fungi, and the chromosomes of some bacteria (Belfort, Previously, we isolated two human L1 elements (L1.2
1993). They are subdivided into two general classes and LRE2) as the likely precursors of germline insertions
based upon their structure. Long terminal repeat (LTR)- into the factor VIII (Dombroski et al., 1991) and dys-
containing retroelements, typified by yeast Ty1, possess trophin genes (Holmes et al., 1994). Each element con-
LTRs and resemble retroviruses, but lack an envelope tained two intact reading frames and encoded an RT
(env) gene. Non-LTR retroelements (also called poly(A) activity in yeast Ty1-based expression systems(Mathias
retroelements) lack LTRs and usually end with a poly- et al., 1991; Dombroski et al., 1994; D. Sassaman, per-
adenylic acid (poly(A)) or short A-rich tail. sonal communication).
Certain retroelements from each class are mobile ge- Here we show that L1.2 and LRE2 are capable of high
netic sequences (retrotransposons) that insert into new frequency autonomous retrotransposition in a cultured
genomic locations via reverse transcription of an RNA human cell line, and that efficient retrotransposition re-
intermediate by a process termed retrotransposition. quires phylogenetically conserved regions of the ORF1
The retrotransposition mechanism of LTR retrotranspo- and ORF2 proteins. Remarkably, we also find that L1.2
sons is analogous to that of retroviruses (Boeke and retrotransposes at a high frequency in a mouse fibro-
Chapman, 1991). By contrast, the retrotransposition blast cell line (L cells). Therefore, we suggest that engi-
mechanism of the two non-LTR retrotransposons stud- neered L1 elements may be useful for transposon muta-
ied (the R2 element from Bombyx mori and the mito- genesis of mammalian genomes.
chondrial group II introns aI1 and aI2 from Saccharo-
myces cerevisiae) involves target site–primed reverse
Resultstranscription beginning at a site-specific single-strand
break in recipient DNA (Luan et al., 1993; Luan and
A System to Detect L1 Retrotransposition
To determine whether L1.2 could retrotranspose in cul-
tured cells, we cloned a reporter cassette (mneoI) de-† Present address: Department of Genetics, Children’s Hospital of
Philadelphia, Philadelphia, Pennsylvania 19104 signed todetect rare retrotransposition events (Freeman
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Figure 1. An L1 Retrotransposition Assay
(A) Organization of a 6.0 kb human L1 ele-
ment. ORF1 and ORF2 are indicated by
closed rectangles, the 59UTR and 39UTR by
stippled rectangles, and the untranslated re-
gion between ORF1 and ORF2 by a white
stripe. The approximate positions of the en-
donuclease (EN), reverse transcriptase (RT),
cysteine-rich (C) motif, and poly(A) tail
(AAAAAn) are indicated. Arrows indicate the
target site duplications flanking the element.
(B) An overview of the L1.2mneoI retrotrans-
position assay. L1.2 was tagged with an indi-
cator gene (mneoI) containing an antisense
copy of the neo gene disrupted by intron 2
of the g-globin gene in the sense orientation.
The splice donor (SD) and spice acceptor (SA)
sites of the intron are indicated. The neo gene
is also flanked by a heterologous promoter
(P9) and a polyadenylation signal (A9) denoted
by the hatched rectangles. Transcripts origi-
nating from the promoter driving L1.2mneoI
expression (P) can splice the intron, but con-
tain an antisense copy of the neo gene. G418-
resistant (G418R) colonies should arise only
when this transcript is reverse transcribed,
integrated into chromosomal DNA, and expressed from its own promoter, P9. Although the sequence to the left of the chromosomally integrated
neo gene is actually poly(T) on the strand depicted, for consistency it is shown as poly(A).
et al., 1994) into the 39UTR of L1.2 to create L1.2mneoI does not express endogenous L1s at high levels (Swer-
gold, 1990; Liebold et al., 1990). Moreover, we con-(Figure 1B). The reporter cassette consists of an anti-
structed RT-defective mutant alleles of L1.2mneoI tosense copy of a selectable marker (neo), a heterologous
test whether G418R foci could result from the comple-promoter (P9), and a polyadenylation signal (A9). The neo
mentation of other cellular reverse transcriptases.gene is disrupted by an intron (IVS 2 of the g-globin
We initially tested L1.2mneoI (pJM101) and three mu-gene) in the opposite transcriptional orientation (Figure
tant constructs for their ability to retrotranspose (Figure1B). This arrangement ensures that G418-resistant cells
2B). The first mutant (pJM102) lacks the internal pro-(G418R) will only arise when a transcript initiated from the
moter sequences present in the 910 bp 59UTR of L1.2.promoter driving L1.2mneoI expression (P) is spliced,
The second mutant (pJM103) contains a 3.8 kb deletionreverse transcribed, reintegrated into chromosomal
of L1.2 sequence that eliminates most of the 59UTR, allDNA, and expressed from promoter P9. In contrast, tran-
of ORF1, and the first 2.1 kb of ORF2. The third mutantscripts originating from P9 cannot be spliced, the neo
(pJM105) contains a missense mutation (D702Y) in thegene product cannot be synthesized, and the cells will
RT domain of the ORF2 protein (Mathias et al., 1991).remain sensitive to G418. Similar cassettes were used
The wild-type and mutant constructs and the pCEP4previously to document the formation of processed
vector were transfected into HeLa cells and tested forpseudogenes in yeast and mammalian cells and to dem-
their ability to retrotranspose by use of the selectiononstrate retrotransposition of yeast, Drosophila melano-
scheme outlined in Figure 2C. Several thousand inde-gaster, and mouse retroelements (Boeke et al., 1985;
pendent hygromycin-resistant (HygR) cells (at leastHeidmann et al., 1988; Curcio and Garfinkel, 1991; Derr
5000–10,000 cells per transfection) expressing the con-
et al., 1991; Jensen and Heidmann, 1991; Tchenio et al.,
structs were harvested 12–14 days after transfection,
1993; Maestre et al., 1995).
pooled, and expanded in growth medium supplemented
To achieve high level expression of L1.2mneoI, and to with hygromycin. Serial dilutions of the HygR cells were
avoid the variable expression phenotypes that typically plated in medium containing G418, and after 14 days
plague studies using stably transfected cell lines, we sub- the resistant cells were fixed and stained (Figure 2C).
cloned it into the pCEP4 expression vector to create The retrotransposition frequency was then scored as
pJM101 (Figure 2A). We chose pCEP4 because it repli- the number of G418R colonies per 106 HygR cells plated
cates as a moderate copy number, extrachromosomal (Table 1).
nuclear episome in primate cell lines (Yates et al., 1985) Apparent retrotransposition (Figure 2D; Table 1) was
and contains a hygromycin gene (Hyg) for the selection of readily observed in cultures expressing pJM101 (about
transfected cells. In pJM101, the expression of L1.2mneoI 740 events in 106 cells) or pJM102 (about 335 events in
was controlled by the cytomegalovirus (CMV) immediate- 106 cells), but not in HeLa lines that expressed the dele-
early promoter. Polyadenylation of L1.2mneoI could occur tion (pJM103) or RT-defective mutant (pJM105) (<1
at either the native L1.2 polyadenylation site or at the SV40 event in 106 cells). Moreover, G418R foci were never
poly(A) site present in pCEP4 (Figure 2A.). obtained from cells expressing pCEP4. These data indi-
To avoid complications due to the expression of en- cate that L1.2mneoI autonomously retrotransposes in
dogenous L1 elements, we tested L1.2mneoI for retro- HeLa cells and that the events depend upon the RT
encoded by ORF2.transposition in a cultured human cell line, HeLa, that
L1 Retrotransposition in Mammalian Cells
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Figure 2. Constructs Used in the L1 Retrotransposition Assay
(A) L1.2mneoI was cloned into pCEP4 to create pJM101. pCEP4 contains an origin of replication (Ori) and a selectable marker (Amp) for
prokaryotic cells and an origin of replication (OriP/EBNA) and selectable marker (Hyg) for eukaryotic cells. The direction of transcription of
each gene is denoted by arrows. The features of L1.2mneoI are described in the legend of Figure 1.
(B) Mutant constructs of L1.2mneoI. pJM102 lacks the 910 bp 59UTR of L1.2; pJM103 has a 3.8 kb deletion that deletes most of the 59UTR,
all of ORF1, and the first 2.1 kb of ORF2; pJM105 contains a missense mutation (D702Y) in ORF2. Each of the constructs is in the pCEP4
vector.
(C) Outline of the L1.2mneoI retrotransposition assay. HeLa cells were transfected with the desired constructs by use of lipofectamine.
Hygromycin-resistant (HygR) cells expressing the wild-type and mutant constructs of L1.2mneoI were harvested 12–14 days after transfection
and expanded in medium containing hygromycin. Dilutions of HygR cells were then plated in medium containing G418, and G418R foci were
isolated 12–14 days later.
(D) Results of the retrotransposition assay. G418R foci were fixed to flasks and stained with Giemsa for visualization. Flasks containing cells
transfected with pJM101, pJM102, pJM103, and pJM105 are shown.
L1.2mneoI Retrotransposes into Genomic DNA pooled genomic DNA from approximately 10–20 G418R
foci derived from either pJM101 or pJM102, digested itWe next determined whether L1.2mneoI integrated into
chromosomal DNA or episomal DNA. We isolated and with BamHI, and carried out Southern blot analysis with
Table 1. Retrotransposition Frequencies of Different L1.2mneoI Constructs in HeLa and LTK2 Cells
Retrotransposition Frequency Experimental Range Percent Wild-Type
Construct N (3 1026) (3 1026) Activity
pJM101 (L1.2) 19 740 390–1090 100
pJM102 (L1.2D59UTR) 21 335 110–560 45
pJM103 (L1.2D) 6 ,0.2 ,0.2 ,0.03
pJM104 (LRE2) 3 1140 980–1300 154
pJM105 (D702Y) 20 0.5 0.2–0.8 0.07
pJM101DCMV 4 443 360–550 60
pJM102DCMV 2 ND ND ND
pCEP4 4 ND ND ND
Mouse L cells
pJM101 2 343 240–446 46
pJM102 2 75 59–90 10
pJM105 3 ND ND ND
Individual constructs tested are listed in column 1. N, the number of independent transfections for each construct. ND, no G418R colonies
recovered. The retrotransposition frequencies of each of the constructs used in this study (column 3), the experimental range (column 4), and
the percent wild-type activity (column 5) are reported. The retrotransposition activity was normalized to the frequency observed for JM101.
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Figure 3. L1.2mneoI Retrotransposes into
Different Regions of Chromosomal DNA
(A) Southern blot of G418R clones. Genomic
DNA was isolated from four independent
G418R clones (lanes A–D). Approximately 20
mg of each DNA was restricted with EcoRI
and subjected to Southern blot analysis with
a 0.46 kb neo gene probe. The size of the
molecular mass standards is indicated.
(B) L1.2mneoI retrotransposition results in
precise splicing of the intron present in the
original construct. Genomic DNA from clones
A–D (500 ng) was used as templates in PCR
reactions with primers neo437S and neo-
1808AS, and one-fifth volume of the products
was separated on a 1.0% agarose gel con-
taining ethidium bromide. A 468 bp DNA frag-
ment diagnostic for loss of the intron was
detected in each clone (lanes 2, 3, 4, and
5). In addition, a small amount of a 1361 bp
diagnostic for the original vector was seen in
lanes 2, 3, and 4. Lane 6 contains DNA from
HeLa cells, and lane 7 is a minus DNA control.
A 1 kb molecular mass size ladder (GIBCO
BRL) is in Lane 1.
a neo probe. About 8–12 bands of differing intensity Retrotransposed Copies of L1.2mneoI Are
were present in DNAs of G418R cells, but not in HeLa 59 Truncated and End in a Poly(A) Tail
DNA. The presence of multiple bands suggested that To determine the genomic structure of the retrotrans-
L1.2mneoI integrated into multiple chromosomal loca- posed copies of L1.2mneoI, we cloned the insertions
tions. We also repeated this analysis on 17 individual from events A–D (Figure 3A) and determined their 59
G418R foci isolated from a single experiment and junction sequences. We showed that each retrotrans-
showed that 15 of 17 contained distinct fragment sizes, posed L1.2mneoI insertion first of all contained the en-
indicating that the vast majority, or all, of the G418R foci tire neo coding sequence as well as the SV40 promoter
result from independent retrotransposition events (data (P9); second, inserted into distinct genomic locations;
not shown). and third, was variably 59 truncated (Figure 4). Insertion
To facilitate cloning of the L1.2mneoI retrotransposi- A is 2.88 kb long and ends at position 4762 of L1.2;
tion events, we modified the assay depicted in Figure insertion B is 1.62 kb long and ends at position 5983 of
2B and directly selected for G418R foci 3 days after L1.2; insertion C is 1.59 kb long and is truncated 7 bp
transfection. We reasoned that eliminating the hygro- after the neo polyadenylation site; insertion D is 2.15 kb
mycin selection step would enrich for G418R cells that long and ends at position 5438 of L1.2 (Figure 4).
contain a retrotransposition event, but either lack or We next determined the 39 junction sequence of each
contain reduced amounts of the original vector. Once insertion. Surprisingly, none of the insertions utilized the
again, we found that G418R foci were obtained from native L1 poly(A) site present in the 39UTR of L1.2mneoI.
HeLa cells expressing pJM101 and pJM102, but not Instead, each terminated with a variable-length, perfect
from cells expressing pJM103 or pJM105 (data not poly(A) tail added precisely to the SV40 late poly(A)
shown). cleavage site (Conway and Wickens, 1985) in pCEP4,
We isolated DNA from four independent G418R clones 138 bp downstream of the L1.2 39UTR (Figure 4). The
derived from HeLa lines that transiently expressed sizes of the poly(A) tails were as follows: insertion A,
pJM102, restricted it with EcoRI, and performed Southern
35–37 bp; insertion B, 74 bp; insertion C, 70 bp; and
blot analysis with a neo probe. One major restriction frag-
insertion D, 56 bp.
ment was observed in each DNA (Figure 3A). The fragment
sizes ranged from 4.1 kb (clone B) to >12 kb (clone C),
New Copies of L1.2mneoI Arisediffered from the predicted size of the vector fragment
by De Novo Retrotransposition(~10 kb), and were not detected with a pCEP4 vector
We next wished to determine whether L1.2mneoI au-probe. Polymerase chain reaction (PCR) analysis of these
thentically retrotransposed into HeLa genomic DNA orDNAs confirmed the loss of the g-globin intron (Figure 3B).
integrated by gene-converting preexisting L1 elements.Together, these data indicate that L1.2mneoI retrotrans-
poses into numerous sites in chromosomal DNA. Since each insertion contained SV40 sequence at its 39
L1 Retrotransposition in Mammalian Cells
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Figure 4. Genomic Structures of Insertions A–D
Each insertion was compared with its corresponding empty site, which was independently cloned from HeLa genomic DNA. Truncated portions
of L1.2mneoI are shown, and the nucleotide position of the truncation in L1.2 is noted. Closed rectangles are L1.2 sequences, and hatched
rectangles are the SV40 promoter and SV40 poly(A) signal at the two ends of the antisense neo gene. Stippled rectangles are transduced
sequences between the 39 end of L1.2 and the SV40 poly(A) site derived from the pCEP4 vector. Open rectangles represent genomic DNAs.
Right arrows indicate target-site duplications. The length of the poly(A) tracts and the sizes of the target site duplications and deletions are
indicated. The arrow flanking insertion A is marked parenthetically because the target site could be a 1–2 bp duplication, a blunt insertion,
or an up to 4 bp deletion.
terminus (just prior to the poly(A) tract), and two of the Retrotransposed Copies of L1.2mneoI
Insert into Different Chromosomesinsertions have neo sequence at their 59 terminus, we
To determine whether L1.2mneoI retrotransposed intothought that gene conversion was unlikely. However,
various chromosomes, we synthesized primers specificwe sought formal proof of this point. To this end, we
for genomic sequences flanking each of the insertionsindependently cloned each of the empty sites present
and mapped their chromosomal locations by PCR ofin HeLa genomic DNA and compared its sequence with
DNA from a monochromosomal rodent/human hybridthat flanking the insertions (Figure 4). In every case,
cell panel (Coriell Cell Repositories). In each case, athe empty site lacked endogenous L1 sequence at or
single band of the predicted size was seen in only oneimmediately flanking the insertion site and was present
of the hybrid samples (data not shown). Insertion Aon only one chromosome (see below).
mapped to chromosome 3, insertion B mapped to chro-Each L1.2mneoI retrotransposition resulted in an al-
mosome 12, insertion C mapped to chromosome 7, andteration of the target site sequence (Figure 4). Insertion
insertion D mapped to chromosome 19 (Figure 4).B was flanked by an unusually long target site duplica-
tion of 214 bp, while insertion D was flanked by a target
site duplication of 32–34 bp residing in a T-rich stretch L1.2mneoI Retrotransposition Requires
of DNA. By contrast, insertion C resulted in a short target the ORF1 Protein
site deletion of 5 bp. Since insertion A retrotransposed L1.2 ORF1 encodes a 40 kDa nucleic acid–binding pro-
into a stretch of 6 A residues, its target site could not tein (Holmes et al., 1992; Hohjoh and Singer, 1996). To
be unambiguously determined. The insertion is flanked determine whether this protein is critical for retrotrans-
by two As at its 59 end and contains a poly(A) tail at its position, we introduced a nonsense mutation into ORF1
39 end. Therefore, we could not differentiate among a and assayed the mutant construct. pJM108 (S119X) has
short duplication of 1 or 2 bp, a small deletion of the a stop codon at nucleotide 1265 of ORF1 that truncates
target site of up to 4 bp, and blunt-ended insertion that the protein by 219 amino acids (Figure 5A). This mutation
did not result in either a duplication or deletion of the abolishes the ability of L1.2mneoI to retrotranspose in
target sequence. Although the variation in the structure HeLa cells (Table 2).
of the target sites is greater than that seen with genomic To identify functionally important amino acids in the
L1s, the absence of L1 sequences at or near the target ORF1 protein, we compared the amino acid sequence
sites and the alterations created upon insertion clearly of L1.2 ORF1 with the ORF1 sequences of mouse, rat,
and rabbit L1s (Burton et al., 1986; Demers et al., 1986;rule out integration via a gene conversion mechanism.
Cell
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Figure 5. Mutant Constructs of L1mneoI
Transfected into HeLa Cells
The approximate positions of ORF1, ORF2,
and D39UTR mutants are indicated. Each mu-
tant was constructed in the pJM102 back-
bone and lacks the 59UTR sequence of L1.2.
Wild-type amino acids that were mutated are
underlined, and the resulting mutant se-
quence is shown below.
Hohjoh and Singer, 1996; T. P. N., unpublished data). promoter from pJM101 tocreate pJM101DCMV.The retro-
transposition frequency of pJM101DCMV was about 60%This analysis revealed three conserved blocks of amino
that of pJM101 (see Table 1).To confirm that the promoteracids near the C-terminus of the ORF1 protein (ARR
activity in pJM101DCMV resided in the 59UTR and notat residues 260–262, REKG at residues 235–238, and
elsewhere in the vector, we showed that a construct lack-YPAKLS at residues 282–287). We mutated the con-
ing both the CMV promoter and the 59UTR (pJM102DCMV)served amino acids to alanines to create pJM109,
was unable to retrotranspose (Table 1).pJM110, and pJM111 (Figure 5).Each mutant retrotrans-
posed at <1% the frequency of the wild-type construct
LRE2 Retrotransposes at a High Frequency(Table 2), indicating that ORF1 is required for retrotrans-
in HeLa Cellsposition.
We next tested whether another potentially active L1
element, LRE2, could retrotranspose in HeLa cells. LRE2A Cysteine-Rich Motif in the C-Terminal End
contains two intact reading frames; the encoded pro-of ORF2 Is Critical for Retrotransposition
teins differ from L1.2 at 17 amino acid residues, butTo define other regions of ORF2 critical for retrotranspo-
none of these differences occur in conserved functionalsition, we made mutations in the cysteine-rich region of
domains (Holmes et al., 1994). LRE2 was tagged withORF2, which is highly conserved (Fanning and Singer,
the indicator cassette, cloned into pCEP4 (pJM104), and1987). We mutated two cysteine residues to serines
assayed for retrotransposition. LRE2 retrotransposes at(CxxxC at residues 1143 and 1147 to SxxxS) to create
a higher frequency than L1.2 (about 1140 events in 106pJM106. We also mutated two other conserved blocks
cells, as compared with 740 events in 106 cells; seeof amino acids toalanines (HMKK at residues 1091–1094
Table 1) despite its lower RT activity. These data showto AAAA and SSS at residues 1096–1098 to AAA) to
that at least two retrotranspositionally active L1 ele-create plasmids pJM112 and pJM113 (Figure 5). Each
ments reside in the human genome.mutation significantly reduced the retrotransposition
frequency (Table 2). However, we reproducibly recov-
A Human L1 Element Retrotransposes
ered a detectable number of events (about 1% of wild-
in a Mouse Fibroblast Cell Line
type levels) from pJM106 and pJM112 (Table 2).
The observation that retrotransposition events in HeLa
cells occur at numerous, distinct chromosomal loca-
The 39UTR of L1.2mneoI Is Not Required tions led us to investigate whether L1 elements could be
for High Frequency Retrotransposition
The 39UTR of R2Bm is critical for reverse transcription Table 2. Retrotransposition Frequencies of ORF1 and ORF2
in vitro and presumably retrotransposition in vivo (Luan Mutants of L1.2mneoI Constructs in HeLa Cells
et al., 1993; Luan and Eickbush, 1995). However, our Construct N Percent Activity
observations that the native L1 polyadenylation signal
pJM102 21 100is bypassed in favor of the SV40 polyadenylation signal
ORF1 mutantsin the pCEP4 vector suggested that the 39UTR of L1.2
pJM108 (S119X) 6 ,0.06
may be dispensible for retrotransposition. To ascertain pJM109 (REKG–AAAA) 3 0.4
the importance of the 39UTR , we deleted 145 bp that pJM110 (YPAKLS–AAAALA) 3 0.1
included a conserved polypurine tract (Usdin and Fu- pJM111 (ARR–AAA) 3 ,0.06
ORF2 mutantsrano, 1989) from the 39UTR of pJM102 to create pTN101
pJM105 (D702Y) 20 0.15(Figure 5). Interestingly, this deletion had little effect
pJM106 (CxxxC–SxxxS) 9 0.24on the retrotransposition frequency of L1.2 (Table 2),
pJM112 (HMKK–AAAA) 3 1.0
indicating that the polypurine tract present in the L1 pJM113 (SSS–AAA) 3 0.2
39UTR is not required for retrotransposition in our assay. 39UTR mutant
pTN101 4 90
The L1 Promoter Is Sufficient for Retrotransposition Individual constructs tested are listed in column 1. N, the number
of independent transfections for each construct. The percent wild-in HeLa Cells
type activity is shown in column 3. The activity was normalized toThe L1 59UTR contains a promoter (Swergold, 1990; Mina-
the value reported for JM102, since all of the mutants were con-kami et al., 1992). To determine whether the L1 promoter
structed in the pJM102 backbone.
was sufficient for retrotransposition, we deleted the CMV
L1 Retrotransposition in Mammalian Cells
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used for transposon mutagenesis. In a first step toward Our system solves all of these problems. We detected
developing this technology, we asked whether L1.2- autonomous retrotransposition at frequencies 2–3 or-
mneoI could retrotranspose in a cultured mouse fibro- ders of magnitude greater than any potential effects due
blast cell line (L cells). to endogenous L1 elements. This allows us to score
pJM101, pJM102, pJM103, pJM105, and pCEP4 were 100- to 200-fold effects of mutation on retrotransposi-
transfected into mouse LTK2 cells and tested for retro- tion frequency. We also compared the sequence of ge-
transposition according to the selection scheme shown nomic DNA flanking each L1.2mneoI insertion with the
in Figure 2C. A high frequency of G418R foci was ob- sequence of the analogous empty site in untransfected
tained from cell lines expressing the wild-type con- HeLa cells. In each case, the tagged element inserted
structs, but not from cell lines expressing the mutants into a previously empty site. The structure of the inser-
(Table 1). We further used Southern blot analysis and tions and their flanking sequences, coupled with the
PCR to confirm that L1.2mneoI integrated into different absence of L1 sequence in all four empty sites, demon-
chromosomal locations of theLTK2 genome and lacked strates that L1.2mneoI retrotransposition faithfully mim-
the intron present in the original construct (data not ics genomic retrotransposition and does not occur by
shown). Since the human L1s retrotranspose in mouse gene conversion of preexisting L1s. Consistent with this,
cells, our data suggest that cellular factors involved in we further show in the accompanying paper that L1.2
the retrotransposition process are evolutionarily con- encodes an endonuclease required for retrotransposi-
served. tion (Feng et al., 1996 [this issue of Cell]).
Finally, we found that, like the vast majorityof endoge-
Discussion nous L1 elements, each L1.2mneoI insertion was vari-
ably 59 truncated. Interestingly, two of the insertions (B
High Frequency Mammalian Retrotransposition and C, Figure 4) were truncated immediately after the
We showed that human L1.2 and LRE2 can autono- neo polyadenylation site. Since a retrotransposition
mously retrotranspose from an episomal vector into ge- event must be at least 1.6 kb long to confer G418 resis-
nomic DNA at a high frequency in human and mouse tance to cells, and many native L1s are <1 kb long, it is
cell lines. We found that HeLa cell lines expressing either probable that numerous shorter undetectable events
LRE2 or L1.2 acquire a retrotransposition event at a also exist. Therefore, it is likely that the overall retro-
remarkably high frequency. Characterization of four in- transposition frequency is considerably greater than we
sertions revealed the following hallmarks of retrotrans- report.
position events: insertion into different locations in chro-
mosomal DNA; variable 59-end truncation; termination
in a poly(A) tail, ranging from 37 to 74 bp; and creation ORF1 and ORF2 Proteins Are Required
of variable-length target site duplications or short dele- for High Frequency Retrotransposition
tions. We provide direct evidence that both ORF1 and ORF2
Previous efforts to reproduce L1 retrotransposition encode proteins required for retrotransposition. Muta-
have been limited. Evans and Palmiter suggested that tions affecting the ORF1 protein reduce the retrotrans-
a mouse L1 element could retrotranspose in a Chinese
position rate of L1.2 by 2–3 orders of magnitude. Previ-
hamster kidney cell line (Evans and Palmiter, 1991). They
ous biochemical studies revealed that ORF1 encodes a
tagged the 59UTR of a mouse L1 element containing
40 kDa nucleic acid–binding protein that colocalizes
two intact ORFs with a heterologous intron and, by PCR,
with L1 RNA in a high molecular mass complex in thefound copies of the element lacking the intron in geno-
cytoplasm of both cultured mouse and human cell linesmic DNA at very low frequency. However, these qualita-
(Martin, 1991; Hohjoh and Singer, 1996). It is likely thattive experiments were limited in value, since no putative
this complex is an intermediate in the L1 retrotransposi-insertions were characterized. Moreover, the retrotrans-
tion process, and we are currently investigating whetherposition frequency reported was not effected by dele-
any of our ORF1 mutations affect complex formation ortion of the RT domain of the L1 element. We therefore
nucleic acid binding.conclude that the mouse L1 element did not autono-
Mutational analysis of ORF2 demonstrated at leastmously retrotranspose, and we suggest that the low
two functions of the protein required for retrotransposi-frequency events were processed pseudogenes formed
tion, reverse transcriptase activityand a function associ-through the action of endogenous cellular RTs.
ated with the cysteine-rich motif. Since we have foundOther attempts to study retrotransposition in higher
that mutations in this cysteine-rich motif do not affecteukaryotic systems have been partially successful. For
the RT activity encoded by ORF2 in a Ty1-based expres-instance, in the offspring of hybrid dysgenic crosses,
sion system (J. V. M. unpublished data), it is likely thatboth a defective Drosophila I factor (Pe´lisson et al., 1991)
this domain provides a function distinct from reverseand a putative active I factor (Jensen and Heidmann,
transcription. These data, along with the demonstration1991) tagged with indicator cassettes gave retrotrans-
of an endonuclease domain at the N-terminus of L1position frequencies of approximately 1 in 104 cells. Ad-
ORF2 (Feng et al., 1996), support the notion that ORF2ditionally, a tagged mouse IAP element retrotransposed
is a modular protein. Interestingly, recent studies on thein a mouse trophoblastoma cell line at frequencies of 1–2
protein encoded by the yeast mitochondrial group IIevents per 106 cells (Heidmann and Heidmann, 1991).
intron aI2 also found that distinct domains of the proteinHowever, these experiments had two limitations. First,
play discrete roles in its retrotransposition (Moran et al.,in neither case could retrotransposition be directly at-
1995; Zimmerly et al., 1995a, 1995b).tributed to the proteins encoded by the element. Sec-
Last, it is noteworthy that even though the D702Yond, the frequency of events was too low to allow func-
tional analysis of mutations in the element. mutation is known to abolish RT activity (Mathias et al.,
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1991; Dombroski et al., 1994), the construct containing suggest that the L1 59UTR serves as an RNA polymerase
III promoter in vitro (Kurose et al., 1995). It remains possi-this mutation reproducibly generated G418R colonies at
a very low frequency (1 event in 106–107 cells). These ble that both RNA polymerases can generate transcripts
that serve as retrotransposition intermediates. Interest-events may be due to the action in trans of endogenous
L1 RT or other cellular reverse transcriptases on the ingly, recent experiments demonstrate that a Drosophila
LTR retrotransposon, mdg1, is transcribed by both RNAepisomally derived L1.2 transcript. Accordingly, the fre-
quency of these events is similar to that previously re- polymerase II and RNA polymerase III (Arkhipova, 1995).
One of the four integrants we characterized had anported for processed pseudogene formation in HeLa
cells (Maestre et al., 1995). unusually longtarget site duplicationof 214 bp. Although
an 82 bp target site duplication has been seen in a
mouse IAP insertion (Tanaka and Ishihara, 1995), theInteresting Features of L1.2mneoI Insertions
Retroviruses can transduce cellular genes to become long duplication associated with insertion B is ten times
larger than any duplication seen with natural L1 inser-oncogenic (Swain and Coffin, 1992). Likewise, the trans-
duction of a cellular gene by an LTR retrotransposon tions. Any proposed mechanism of L1 integration will
need to account for target site duplications of this un-was recently observed (Bureau et al., 1994). Our experi-
ments show that L1 can similarly transduce flanking usual size. In the accompanying paper, we show that
L1.2 encodes an endonuclease required for retrotrans-DNA. In every insertion we characterized, the L1.2
position (Feng et al., 1996). We speculate that the endo-poly(A) signal was bypassed, and polyadenylation oc-
nuclease cleaves genomic DNA to liberate a 39-OH thatcurred precisely at the SV40 poly(A) cleavage site in the
serves as a primer for reverse transcription of the L1pCEP4 vector. We previously reported that a read-
mRNA. Perhaps cellular helicases acting at the site ofthrough transcript of LRE2 retrotransposed, giving rise
the initial target site lesion contribute to the variable-to a disease-producing insertion containing 489 bp of
size target site duplications encountered.unique sequence between the 39 end of the L1 element
The short 5 bp deletion at the target site of insertionand the site of polyadenylation (Holmes et al., 1994). It
C is also interesting. Recent studies show that retro-is likely that many other L1 elements contain relatively
transposition of a Drosophila I factor can induce dele-weak poly(A) signals. This feature allows transduction of
tions of the target site (Jensen et al., 1994), and an L1DNA sequences 39 to the element, provided that another
insertion into the dystrophin gene resulted in a 2 bpstrong poly(A) signal is in its vicinity. In this regard, it
deletion (Narita et al., 1993). We therefore conclude thatwill be interesting to determine whether longer tracts of
short deletions at the target site may accompany theDNA inserted between L1.2 and the SV40 poly(A) sites
retrotransposition of non-LTR retroelements at a higherin L1.2mneoI can be transducedupon retrotransposition
frequency than previously believed.and whether L1 elements can transduce intact genes.
The finding that the L1 39UTR is dispensible for retro-
Can Human L1 Elements Be Usedtransposition was somewhat surprising, considering
in Transposon Mutagenesis?that rat and mouse L1s also contain a conserved poly-
Transposon mutagenesis has been valuable in identi-purine tract in this region (Usdin and Furano, 1989). We
fying and cloning genes in other model systems. Forthus conclude that the L1 39UTR does not serve as a
instance, P elements have routinely been used in Dro-binding site for the element-encoded RT, as is the case
sophila to generate a wide variety of mutant phenotypesfor the R2 element of B. mori (Luan and Eickbush, 1995).
that result from the insertion of the P element into orInstead, it may be important in defining or activating the
near a gene of interest. As a consequence of insertion,native L1 polyadenylation site. In that case, deletion of
thegene of interest is tagged with P-element sequences,the SV40 poly(A) site in pCEP4 should markedly affect
which allows cloning of the DNA surrounding the P ele-either the retrotransposition frequency or the structure
ment integration site and rapid isolation of the full-lengthat the 39 end of the L1.2mneoI insertions.
gene (Cooley et al., 1988). For obvious reasons, transpo-We report that L1.2 retrotransposition requires either
son mutagenesis would be an extremely powerful toolthe presence of thenative L1 promoter or a heterologous
for analysis of the mammalian genome.(CMV) promoter. Deletions of both promoters led to a
In the case of L1-driven insertions, the tag would beloss of retrotransposition, but the inclusion of both did
a nonhuman gene such as the neo gene used in thisnot dramatically increase its frequency. Since both en-
study. Such a tag would allow discrimination of thedogenous L1 expression and L1 promoter activity are
markedL1s from the numerousendogenous L1spresentat reportedly low levels in HeLa cells (Swergold, 1990;
in human cells. Further, we showed that tagged humanLiebold et al., 1990; Minakami et al., 1992), our findings
L1s can retrotranspose into different genomic locationswere unexpected and suggest that native full-length L1
in a mouse fibroblast cell line. We can now obtain 105elements may retrotranspose in HeLa cells at a higher
independent retrotransposition events in LTK2 cells. Afrequency than previously thought. Alternatively, the ex-
similar retrotransposition frequency in mouse embry-pression of episomal L1 elements may be more robust
onic stem cells will allow us togenerate mice with taggedthan that of endogenous L1s.
insertional mutationsat numerous random genomic loci.Each of the retrotransposition events characterized
was generated from pJM102 (a construct that contains
Experimental Proceduresthe CMV promoter, but lacks the 59UTR) and ends with
a poly(A) tail; therefore we conclude that an RNA poly- Oligonucleotides and Plasmids
merase II transcript is an intermediate in the L1 retro- Oligonucleotide sequences used in this study are available upon
request. L1.2A (Dombroski et al., 1991) was enginered to contain atransposition process. However, recent experiments
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unique NotI restriction site upstream of its 59UTR or immediately general, reactions were carried out at an annealing temperature 58C
below the Tm of the primer. One-fifth of the reaction volume wasupstream of ORF1. The BamHI site at position 4836 of L1.2 was then
destroyed by site-directed mutagenesis (changed from GGATCC to separated on 1.0% agarose gels containing ethidium bromide.
GGACCC), thereby leaving a unique BamHI site flanking the 39 end
of the element (in the polylinker of pBLS KS2). A unique SmaI site Southern Blots
was introduced into the L1.2 39UTR at position 5980 by site-directed DNA samples were restricted with the restriction enzymes (New
mutagenesis (changing the sequence 59-CCTGCA to 59-CCCGGG). England Biolabs) noted in the text and fractionated on 0.7%–1.0%
A blunt-ended 2.1 kb EcoRI–BamHI fragment containing the neo agarose gels containing ethidium bromide. Southern blots were
indicator cassette (Holmes, 1994) was cloned into the SmaI site, done as described (Sambrook et al., 1989). DNA probes to the neo
resulting in plasmids that contained a tagged L1.2 element that gene were labeled with the multiprime DNA labeling system (Amer-
either had (pJCC9) or lacked (pJCC8) the L1.2 59UTR. Subcloning sham) to high specific activity with [a-32P]-dCTP (Amersham).
of the 8.1 kb NotI–BamHI fragment from pJCC9 or the 7.2 kb NotI–
BamHI fragment from pJCC8 into pCEP4 (InVitrogen) created Library Construction and Screening
pJM101 and pJM102, respectively. A 0.75 kb BglII restriction frag- EcoRI restriction fragments containing the L1.2mneoI insertions
ment was deleted from pCEP4, creating pCEP4DCMV. Subcloning were isolated from agarose gels with GeneClean (Bio 101, Inc.),
of the 8.1 kb NotI–BamHI fragment from pJCC9 or the 7.2 kb NotI– were checked for the spliced neo gene by PCR (as in Figure 3B),
BamHI fragment from pJCC8 into pCEP4DCMV created pJM101- and were cloned into the following phage: lgt10 (Promega; insertion
DCMV and pJM102DCMV, respectively. Deletion of a 3.8 kb AflII B), lDASHII (Stratagene; insertions C and D), or lZAPII (Stratagene;
fragment from pJM101 yielded pJM103. Replacement of the 5.9 kb insertion A). Phage were packaged by using either Promega Pack-
fragment in pJM101 with a 5.9 kb AccI fragment from LRE2 (Holmes agene or Stratagene Gigapack III packaging extracts and plated at
et al., 1994) created pJM104. Deletion of the 145 bp downstream a density of 10,000–30,000 phage per plate. Approximately 200–
of the stop codon in pJM102 created pTN101. All of the ORF1 800,000 clones from each library were screened with a 0.46 kb neo
and ORF2 mutations were generated by site-directed mutagenesis gene (Sambrook et al., 1989). Secondary and tertiary screens were
(Kunkel et al., 1991), and relevant restriction fragments containing used to purify positive clones further.
the mutation were sequenced in their entirety. Each mutant was
subcloned into pJCC8, and the 7.2 kb NotI–BamHI fragment of each Characterization of Empty Genomic Sites in HeLa DNA
mutant was cloned into pCEP4. The empty sites for insertions A–D were amplified by PCR using
oligonucleotide primers that flanked the insertion site. The sequence
DNA Preparation and Sequencing flanking each empty site was checked for repetitive sequences by
Plasmid DNAs were purified on Qiagen maxi or midi prep columns. use of the BLAST algorithm (BCM search launcher) to scan the
DNAs for transfection experiments were checked for superhelicity sequences in GenBank and an EST database (Altschul et al., 1990).
by electrophoresis on 0.6% agarose–ethidium bromide gels. Only Sequences in nonrepetitive DNA flanking each insertion were used
highly supercoiled preparations of DNA (>90%) were used for trans- to design oligonucleotide probes. Those probes were used in PCR
fection. Genomic DNA from tissue culture cells was isolated by reactions with HeLa genomic DNA. In every case, a single band of
established methods (Sambrook et al., 1989). DNA sequencing was the predicted size was amplified.
done with an Applied Biosystems DNA sequencer (ABI 377).
Genomic Localization of the L1.2mneoI
Growth of Cells Retrotransposition Events
HeLa cells and mouse LTK2 cells were grown at 378C in an atmo- Insertions were mapped by using PCR on 100 ng of genomic DNA
sphere containing 7% carbon dioxide and 100% humidity in high from a monochromosomal human/rodent somatic cell hybrid panel
glucose Dulbecco’s modified Eagle’s medium (DMEM) lacking py- purchased from the Coriell Cell Repositories. For each retrotranspo-
ruvate (GIBCO BRL). DMEM was supplemented with 10% fetal bo- sition event, primers were chosen in the vicinity of the insertion site
vine calf serum (FCS), 0.4 mM glutamine, and 20 U/ml penicillin– from presumptive single-copy sequences after database searches.
streptomycin (DMEM-complete). Cells were passaged by standard The primer sequences used to map each insertion are available
methods. upon request.
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